首页 | 本学科首页   官方微博 | 高级检索  
检索        

绝经状态对女性冠心病患者植入药物支架后长期结局的影响
引用本文:王翔飞,扎西多杰,王齐兵,樊冰,钱菊英,葛雷,马建英,张峰,姚康,葛均波.绝经状态对女性冠心病患者植入药物支架后长期结局的影响[J].中国临床医学,2021,28(2):258-261.
作者姓名:王翔飞  扎西多杰  王齐兵  樊冰  钱菊英  葛雷  马建英  张峰  姚康  葛均波
作者单位:复旦大学附属中山医院心内科, 上海 200032
基金项目:国家重点研发计划(2019YFC0840601).
摘    要:目的:探讨女性未绝经状态与冠心病植入药物支架后结局的关系。方法:回顾性分析2008年1月至2014年12月复旦大学附属中山医院数据库中小于55岁、植入药物支架的143例女性冠心病患者病例资料。根据介入手术时的绝经状态分为未绝经女性组(n=50)和已绝经女性组(n=93)。结果:与已绝经女性组相比,未绝经女性组年龄更小、冠心病家族史比例更高,但两组其他常见冠心病危险因素差异无统计学意义。两组患者起病方式和手术特点差异无统计学意义。中位随访时间823 d。两组主要心脏不良事件(major cardiac adverse events, MACEs)的发生率差异无统计学意义,无事件生存率差异无统计学意义。Cox回归分析显示,肾小球滤过率下降和多支血管病变是MACEs的预测因素(P0.05),未绝经状态不是MACEs的预测因素。结论:在女性冠心病患者中,未绝经状态不是MACEs的影响因素。

关 键 词:冠心病  经皮介入治疗  药物支架  女性  绝经
收稿时间:2020/8/14 0:00:00
修稿时间:2020/10/7 0:00:00

Effect of menopausal status on long-term outcome of women undergoing drug-eluting stent implantation
WANG Xiang-fei,DORJE Ta-shi,WANG Qi-bing,FAN Bing,QIAN Ju-ying,GE Lei,MA Jian-ying,ZHANG Feng,YAO Kang,GE Jun-bo.Effect of menopausal status on long-term outcome of women undergoing drug-eluting stent implantation[J].Chinese Journal Of Clinical Medicine,2021,28(2):258-261.
Authors:WANG Xiang-fei  DORJE Ta-shi  WANG Qi-bing  FAN Bing  QIAN Ju-ying  GE Lei  MA Jian-ying  ZHANG Feng  YAO Kang  GE Jun-bo
Institution:Department of Cardicology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Abstract:Objective: To explore the relationship between menopausal status and long-term outcome of patients with coronary heart disease (CHD) after drug-eluting stent implantation. Methods: The data of 143 patients with CHD who were less than 55 years old and implanted with drug-eluting stents in Zhongshan Hospital, Fudan University from January 2008 to December 2014 were retrospectively analyzed. According to the status of menopause, patients were divided into premenopausal women group (n=50) and postmenopausal women group (n=93). Results: Compared with the postmenopausal women, the premenopausal women were younger, and had a higher rate of positive family history of CHD. The median follow-up time was 823 days. The incidence of major cardiac adverse events (MACEs) was not significantly different between the two groups. The event-free survival rate was not significantly different between the two groups. Cox regression analysis showed that the independent predictors of MACEs included the multi-vessel disease and lower estimated GFR other than menopausal status. Conclusions: In women with CHD, the premenopausal status might not be a influence factor for MACEs.
Keywords:coronary artery disease  percutaneous coronary intervention  drug-eluting stent  female  menopause
本文献已被 CNKI 等数据库收录!
点击此处可从《中国临床医学》浏览原始摘要信息
点击此处可从《中国临床医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号